List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 6 studies with search of: "Favrille" [Exact]
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Active, not recruiting Vaccine Therapy and Sargramostim Compared With Placebo and Sargramostim Following Rituximab in Treating Patients With Non-Hodgkin's Lymphoma
Condition: Lymphoma
Interventions: Biological: autologous immunoglobulin idiotype-KLH conjugate vaccine;   Biological: rituximab;   Biological: sargramostim
2 Recruiting Vaccine Therapy and GM-CSF in Treating Patients With Progressive Non-Hodgkin's Lymphoma
Condition: Lymphoma
Interventions: Biological: autologous immunoglobulin idiotype-KLH conjugate vaccine;   Biological: sargramostim
3 Active, not recruiting Idiotype Vaccine for Low-Grade Non-Hodgkin's Lymphoma
Condition: Lymphoma, Low-Grade
Intervention: Biological: FavId (Id-KLH) active immunotherapy
4 Active, not recruiting Rituxan Plus FavId (Idiotype Vaccine) for Low-Grade Non-Hodgkin's Lymphoma
Condition: Non-Hodgkin's Lymphoma
Intervention: Biological: Id-KLH
5 Suspended GM-CSF With or Without Vaccine Therapy After Combination Chemotherapy and Rituximab as First-Line Therapy in Treating Patients With Stage II, Stage III, or Stage IV Diffuse Large B-Cell Lymphoma
Condition: Lymphoma
Interventions: Drug: autologous immunoglobulin idiotype-KLH conjugate vaccine;   Drug: cyclophosphamide;   Drug: doxorubicin hydrochloride;   Drug: prednisone;   Drug: rituximab;   Drug: sargramostim;   Drug: vincristine;   Procedure: Intervention/procedure;   Procedure: antibody therapy;   Procedure: biological therapy;   Procedure: chemotherapy;   Procedure: colony-stimulating factor therapy;   Procedure: cytokine therapy;   Procedure: monoclonal antibody therapy;   Procedure: non-specific immune-modulator therapy;   Procedure: therapeutic procedure;   Procedure: tumor cell derivative vaccine;   Procedure: vaccine therapy
6 Recruiting Rituximab, Vaccine Therapy, and GM-CSF in Treating Patients With Non-Hodgkin's Lymphoma
Condition: Lymphoma
Interventions: Biological: autologous immunoglobulin idiotype-KLH conjugate vaccine;   Biological: rituximab;   Biological: sargramostim

Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services